Home
About
Overview
Leadership Team
Board of Directors
Contact
Pipeline
Overview
AVTX-009
Under Strategic Review
Patients and Families
Overview
Patient Advocacy
Access to Investigational Therapies
Investors
Overview
News / Events
Company Information
Analyst Coverage
Stock Data
SEC Filings
Annual Report & Proxy
Corporate Governance
Resources
Access to Investigational Therapies
Careers
All SEC Filings
Investors
Investors
Overview
News / Events
Press Releases
IR Calendar
Email Alerts
Company Info
Profile
Presentations
Leadership Team
Contacts
FAQ
Request Information
Analyst Coverage
Stock Data
Quote
Charts
Historical Data
IRS Form 8937
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Annual Report & Proxy
Governance
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
All SEC Filings
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
25-NSE
3
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Date
Form
Description
PDF
XBRL
Pages
04/29/15
DRSLTR
Correspondence Related to Draft Registration Statement
4
04/29/15
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
EX-3.1
EX-4.1
EX-4.3
EX-4.7
EX-4.8
EX-4.9
EX-10.8
EX-10.9
442
07/21/14
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
8
05/14/14
UPLOAD
SEC-generated letter
3
04/21/14
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
EX-3.3
EX-4.2
EX-4.3
EX-4.4
EX-4.5
EX-4.6
EX-10.1
EX-10.2
EX-10.10
364
04/18/14
DRSLTR
Correspondence Related to Draft Registration Statement
6
01/16/14
UPLOAD
SEC-generated letter
6
12/20/13
DRSLTR
Correspondence Related to Draft Registration Statement
1
12/20/13
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
223
09/06/13
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
8
90
91
92
93
94
95
96
97
98
99
Email Alerts
Tear Sheet
Contacts
RSS News Feed